Source: Annual Congress 2013 –COPD mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Pobeha, D. Petrasova, R. Tkacova, P. Joppa (Kosice, Slovakia). Plasma osteoprotegerin is related to femoral osteoporosis in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 2141

Member's Comments

No comment yet.

Related content which might interest you: Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome Source: International Congress 2015 – COPD: notable points Year: 2015 Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum levels of RAAS components in COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Serum sirtuin-1 is reduced in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 The potential value of FRAX index and bone turnover markers to identify osteoporosis in COPD patients Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Microparticles in stable and exacerbated COPD patients Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Study of bone mineral density, hemogram and their correlations in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study Source: Eur Respir J 2010; 35: 540-548 Year: 2010 Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013 The relationship between systemic inflammation and vitamin D levels in COPD Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Circulating desmosine relates to cardiovascular comorbidity, coronary artery calcification score (CACS), systemic inflammation and mortality in patients with COPD Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Obesity and bone health in COPD Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Comparison of osteoporosis in male smokers with or without COPD Source: International Congress 2016 – Smoking-related diseases Year: 2016 COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014